Vasodilatory shock
Vasodilatory shock | |
---|---|
Other names | Refractory vasodilatory shock, refractory shock, irreversible shock, vasogenic shock, or vasoplegic shock. |
Multiple organ dysfunction | |
Prevention | Early recognition and rapid treatment initiation for any types of shock. |
Prognosis | Higher than 50% mortality rate within a month[1][dubious ] |
Vasodilatory shock, vasogenic shock, or vasoplegic shock is a
Treatment typically involves uses of
Signs and symptoms
- Confusion or lack of alertness
- Loss of consciousness
- A sudden and ongoing rapid heartbeat
- Sweating
- Pale skin
- A weak pulse
- Rapid breathing
- Decreased or no urine output
- Cool hands and feet
Cause
A
The most common cause of vasodilatory shock is sepsis.[5] Except sepsis, other causes comprise severe acute pancreatitis, post cardiopulmonary bypass vasoplegia and other triggers for a systemic inflammatory response syndrome.[18][19][20][21] Low serum calcium values might take a role in vasodilatory shock.[17]
Pathophysiology
In the cases of
Vasopressin deficiency may play an important role in vasodilatory shock.
Vasodilatory shock is often involved with the dysfunction of physiologic compensatory mechanisms such as the sympathetic nervous system, vasopressin arginine system and renin-angiotensin aldosterone system.[24]
Diagnosis
The definition of refractory shock or vasodilatory shock varies. In 2018, the American College of Chest Physician stated that it is presents if there is an inadequate response to high-dose vasopressor therapy defined as ≥ 0.5 mg/kg/min norepinephrine-equivalent dose.[4]
Drug | Dose | Norepiniphrine equivalent |
---|---|---|
Epinephrine | 0.1 μg/Kg/min | 0.1 μg/Kg/min |
Dopamine | 15 μg/Kg/min | 0.1 μg/Kg/min |
Norepinephrine | 0.1 μg/Kg/min | 0.1 μg/Kg/min |
Phenylephrine | 1 μg/Kg/min | 0.1 μg/Kg/min |
Vasopressin | 0.04 U/Kg/min | 0.1 μg/Kg/min |
Management
Reversing the underlying causes of vasodilatory shock, stabilizing
The initial treatment aiming at restoring effective blood pressure in patients that have refractory shock typically starts with introducing norepinephrine and dopamine.[24] Vasopressin comes as the second-line agent.[24]
However, high-dose therapy is linked to excessive coronary, splanchnic vasoconstriction, and hypercoagulation.
In those whose vasodilatory shock is caused by hypocalcemic cardiomyopathy in the context of dilated cardiomyopathy with documented both reduced heart ejection fraction and contractile performance,[17] the uses of calcium and active vitamin D or recombinant human parathyroid hormone treatment are viable since there were many successful cases reported while given the physiological role of calcium on muscle contraction.[17][30][31][32]
A successful treatment requires leveraging the respective unique contributions of a multi-disciplinary team not only
Epidemiology
Prognosis
Early recognition and rapid treatment initiation are crucial to saving life.].
References
- ^ PMID 28425079.
- ^ S2CID 6900105.
- ^ a b c "National Heart, Lung, and Blood Institute (NHLBI)". Cardiogenic Shock. Retrieved 2019-02-07. This article incorporates text from this source, which is in the public domain.
- ^ S2CID 206678750.
- ^ PMID 27147845.
- ^ PMID 29980217.
- PMID 24151551.
- PMID 28057037.
- PMID 28528561.
- S2CID 33545204.
- PMID 26903338.
- ^ PMID 19919684.
- PMID 23100216.
- ^ "Definition, classification, etiology, and pathophysiology of shock in adults". UpToDate. Retrieved 2019-02-07.
- ^ S2CID 2208904.
- PMID 22828152.
- ^ PMID 30616730.
- S2CID 208361755.
- PMID 15003097.
- PMID 18256381.
- ^ ISSN 2191-5709.
- ^ PMID 11529214.
- ^ ISBN 978-1-4160-2591-7.
- ^ a b c d e f Timothy E. Albertson. "Advances in Vasodilatory Shock: Emerging Data to Address Current Challenges". Medscape Education. Retrieved 2019-02-08.
- S2CID 25225709.
- S2CID 27732980.
- S2CID 26047546.
- S2CID 46959811.
- PMID 29486781.
- PMID 24840807.
- PMID 22430263.
- PMID 28864535.
- PMID 20630594.
- PMID 19400494.
- PMID 29872882.